A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B)

Conditions: Healthy Participants; Hemophilia A; Hemophilia B Interventions: Drug: SR604; Drug: Placebo Sponsors: Equilibra Bioscience LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials